Expert Cautions Against Lowering Approval Standards, Groups Say Still More Work To Be Done

FDA on Tuesday (June 27) announced steps to increase the availability of generic drugs by publishing a list of off-patent, off-exclusivity branded drugs and by speeding reviews of applications to make generic versions of those drugs available until there are three approved generics for a given product. A public health researcher cautioned against FDA lowering standards for generic drug approvals, saying if that were to happen it would be “disastrous to our entire US healthcare system.” And one public policy...